Replies to post #26954 on $heff's $tation of $tocks & $olid DD

[$heff]

POZN ($10.86)…Vimovo is a featured product for Astra Zeneca in their 2009 Shareholder Meeting. POZN is not alone in wanting this product to be approved! A lot on the line here and POZN has a key partner in the U.S. and internationally.